These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Shooting for a faster approach to the immunotherapy target: will cluster become conventional? Cox LS Ann Allergy Asthma Immunol; 2009 Mar; 102(3):177-8. PubMed ID: 19354062 [No Abstract] [Full Text] [Related]
25. Immunologic responses to subcutaneous allergen immunotherapy. Till SJ; Durham SR Clin Allergy Immunol; 2008; 21():59-70. PubMed ID: 18828498 [No Abstract] [Full Text] [Related]
26. Subcutaneous immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases. Malling HJ; Bousquet J Clin Allergy Immunol; 2008; 21():343-58. PubMed ID: 18828516 [No Abstract] [Full Text] [Related]
27. Risk factors for systemic reactions to allergen-specific subcutaneous immunotherapy. Iglesias-Cadarso A; Hernández-Weigand P; Reaño M; Pérez-Pimiento A; Vargas Núñez JA; de la Torre F J Investig Allergol Clin Immunol; 2010; 20(7):621-2. PubMed ID: 21314007 [No Abstract] [Full Text] [Related]
28. Clinical case of anaphylaxis with sublingual immunotherapy: house dust mite allergen. Van Dyken AM; Smith PK; Fox TL J Allergy Clin Immunol Pract; 2014; 2(4):485-6. PubMed ID: 25017545 [No Abstract] [Full Text] [Related]
32. Monitoring the effect of allergen immunotherapy: a clinician's dream comes true? Bullens DM Clin Exp Allergy; 2010 Jul; 40(7):958-61. PubMed ID: 20642573 [No Abstract] [Full Text] [Related]
33. [Adverse reactions to skin tests and immunotherapy in the practice of Mexican allergologists]. Larenas Linnemann D; Rodríguez Pérez N; Becerril M Rev Alerg Mex; 2008; 55(2):62-70. PubMed ID: 19058483 [TBL] [Abstract][Full Text] [Related]
34. Current strategies for allergen-specific immunotherapy at its centenary. Valenta R; Coffman RL Curr Top Microbiol Immunol; 2011; 352():v-vi. PubMed ID: 22145167 [No Abstract] [Full Text] [Related]
35. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy. Crameri R Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139 [TBL] [Abstract][Full Text] [Related]
36. [The progress on allergen-specific immunotherapy for bronchial asthma]. Liu HY; Xie LY; Zhou LF Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):450-4. PubMed ID: 24103210 [No Abstract] [Full Text] [Related]
37. Sublingual immunotherapy: dosing in relation to clinical and immunological efficacy. Larenas-Linnemann DE Allergy Asthma Proc; 2008; 29(2):130-9. PubMed ID: 18430309 [TBL] [Abstract][Full Text] [Related]
38. [Hyposensitization in general practice. A strategic concept]. Jorde W HNO; 1995 Dec; 43(12):741-4. PubMed ID: 8582837 [No Abstract] [Full Text] [Related]